Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DW4421 drug-drug interaction with NSAIDs in healthy volunteers
NCT07343245Phase 1Recruiting
- Sponsor
- Daewon Pharm
- Start
- Dec 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of DW4421-1 (6 cohorts), sponsored by Daewon Pharm. Primary endpoints: Maximum Steady-State Concentration at Day 15 and Area Under the Curve at Steady State Over Dosing Interval at Day 15. Started Dec 2025; status: recruiting.
02
Drugs
DW4421-1
Beyond the preview
Go deeper on NCT07343245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07343245.